Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Choroidal Neovascularization”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)WithdrawnNCT03374670
What this trial is testing

ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Testing effectiveness (Phase 2)UnknownNCT02857517
What this trial is testing

Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Who this might be right for
Idiopathic Choroidal Neovascularization
Jiao Mingfei 50
Large-scale testing (Phase 3)Study completedNCT00370786
What this trial is testing

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Who this might be right for
Choroidal Neovascularization
Shahid Beheshti University of Medical Sciences 31
Not applicableUnknownNCT02597855
What this trial is testing

Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Yeungnam University College of Medicine 29
Large-scale testing (Phase 3)Study completedNCT00000150
What this trial is testing

Submacular Surgery Trials (SST)

Who this might be right for
Macular DegenerationHistoplasmosis
National Eye Institute (NEI)
Not applicableEnded earlyNCT02857894
What this trial is testing

Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)

Who this might be right for
Choroidal Neovascularization
Fondation Ophtalmologique Adolphe de Rothschild 7
Testing effectiveness (Phase 2)Study completedNCT02257502
What this trial is testing

Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients

Who this might be right for
Idiopathic Choroidal Neovascularization
Hospices Civils de Lyon 20
Testing effectiveness (Phase 2)Study completedNCT02397954
What this trial is testing

Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation 4